Atlantic Health System has marked the conclusion of service for four long-standing members of its board of trustees, recognizing the collective contributions of leaders whose combined institutional engagement spans more than five decades of governance, clinical expertise, and financial stewardship at one of New Jersey’s largest and most influential nonprofit health systems. The four departing trustees — Immediate Past Chair Robert E. McCracken, Vice Chair Richard W. Herbst, Dr. John F. Vigorita, and Dr. Grant Parr — represent a cross-section of the professional disciplines that effective health system governance requires: law, finance, medicine, surgery, and the specific kind of long-horizon civic commitment that causes individuals with demanding careers to volunteer sustained years of their professional judgment to an institution that serves their community.
Laura Ann Kelly, Esq., chair of the Atlantic Health board of trustees, characterized the departure of all four members in terms that reflect both the personal and institutional weight of the transitions. “As a nonprofit health care system dedicated to our charitable mission, Atlantic Health relies on the strategic leadership and governance of trustees who generously volunteer their time and talent in support of our patients and caregivers,” Kelly said. “We are endlessly thankful for leaders like Bob, Dick, John and Grant, who choose to give back by advocating for healthier communities and safeguarding the well-being of generations to come.” The statement captures what Atlantic Health’s governance model actually depends on: not compensated executives making calculated professional investments, but individuals with substantial expertise in their own fields who choose to apply that expertise to the healthcare institution’s governance because they believe in what the system is doing for the patients and communities it serves.
Robert E. McCracken, whose departure closes the most recent chapter of what has been a 14-year association with Atlantic Health’s board, joined the board of trustees in 2011 and built a record of institutional engagement that culminated in his election as chair and his subsequent transition to the role of immediate past chair in May 2025, following four years in the chair position. His service on the board’s Governance and Executive Committees kept him at the center of the institution’s most fundamental decisions — questions about leadership, direction, accountability, and the structural integrity of the governance apparatus itself. McCracken’s professional background as a former owner and president of Smith-McCracken and Wood Funeral Homes, combined with his prior service as chair of Newton Memorial Hospital and the Newton Medical Center advisory board before Newton’s affiliation with the Atlantic Health system, gave him a layered understanding of community healthcare that extended from the institutional governance level through the specific experience of serving as a community healthcare leader in one of New Jersey’s smaller regional markets. His continued service on the board of directors of Provident Financial Services ensures that his contribution to New Jersey’s broader civic and commercial life continues beyond his Atlantic Health tenure.
Richard W. Herbst’s relationship with Atlantic Health extends even further back, to his initial joining of the board in 2005, an association of nearly two decades punctuated by a brief departure in 2017 before his return as a trustee in May 2018 and his subsequent appointment as chair of the board’s Audit and Compliance Committee in 2019. The depth and specific nature of Herbst’s professional background gave Atlantic Health access to expertise that nonprofit health systems rarely have on their governance teams at this level: his career as president of Roundtable Investment Partners, a private investment firm, came after years as managing director at JPMorgan and as a partner at Goldman Sachs and Company — a professional trajectory through two of the most demanding and analytically rigorous environments in American finance. His service on Atlantic Health’s Executive and Finance and Investment Committees translated those credentials into direct institutional value, bringing sophisticated expertise in mergers and acquisitions, enterprise risk management, and institutional investment to the governance of a health system whose financial decisions affect thousands of employees, hundreds of physicians, and millions of patients across New Jersey. The 18 years of cumulative board service that Herbst’s tenure represents constitutes a form of institutional knowledge that cannot be formally transferred — it is embedded in the relationships, the context, and the pattern recognition that comes from having watched a complex institution navigate decisions across multiple market cycles, leadership changes, and strategic pivots over nearly two decades.
Dr. John F. Vigorita’s connection to Atlantic Health predates his board membership by many years, rooted in the clinical experience that shaped his professional career from its earliest stages. His residency in pediatrics at Atlantic Health Overlook Medical Center gave him firsthand experience of what the institution is, how it functions at the patient care level, and what the daily reality of practicing medicine within its walls looks like — context that few board members bring to their governance service because few board members have trained and practiced within the institution they govern. That clinical foundation supported a 30-plus-year career as the founder and practicing pediatrician at Summit Pediatric Associates and as president of the Overlook Medical Staff, roles that gave him both broad clinical credibility and specific institutional standing within Atlantic Health’s physician community. Dr. Vigorita’s governance contributions extended from his board membership on the Governance and Finance and Investment Committees to his service as Atlantic Health’s medical director of Mission Development and chair of Bioethics Oversight — roles that placed him at the intersection of the clinical, ethical, and strategic dimensions of health system governance simultaneously. His leadership of accountable care organizations including Optimus Healthcare Partners and Vista Health System brought a population health and value-based care perspective to his board service that reflected the broader direction of American healthcare reimbursement and delivery during his tenure. The creation of physician networks designed to improve quality while reducing costs is among the central strategic challenges facing every major health system in the country, and Dr. Vigorita’s direct, leadership-level experience with that work gave the Atlantic Health board access to a perspective that board members without clinical careers typically cannot provide.
Dr. Grant Parr’s departure from the board closes a chapter that began in 2017 but whose connection to Atlantic Health goes back considerably further — to a specific date that carries the kind of institutional significance that health systems mark carefully. Twenty-nine years before he joined the board of trustees, Dr. Parr performed the first open-heart surgery at what is now Atlantic Health Morristown Medical Center, a moment that represented the beginning of a cardiovascular surgery program whose eventual scope would make it the largest heart program in the state of New Jersey. He performed two open-heart surgeries on that inaugural day, and went on to play what the institution describes as an integral role in the creation of the Gagnon Cardiovascular Institute — the specialized cardiovascular center that now anchors Morristown Medical Center’s heart care program and that represents one of Atlantic Health’s most clinically significant institutional investments. That origin story gives Dr. Parr’s governance service a dimension unavailable to other board members: he was present at the founding moment of one of the institution’s most consequential programs, participated in its growth from inception through its establishment as the dominant heart care program in New Jersey, and then brought that decades-long institutional memory to his service on the board’s Quality, Medical Staff Leadership and Development, and Audit and Compliance Committees. His 18 years of teaching positions at Columbia University added an academic medicine perspective to that clinical foundation, and his six years on the board of the Foundation for Morristown Medical Center extended his institutional engagement into the philanthropic dimension of the health system’s operation. As a board-certified thoracic surgeon who spent his career operating at the intersection of clinical practice, program development, and medical education, Dr. Parr brought to the Atlantic Health board a specific combination of surgical expertise, institutional history, and academic standing that the organization’s governance benefited from in ways that will be difficult to replicate in a single successor.
Atlantic Health System’s reliance on volunteer trustee governance is not incidental to its nonprofit identity — it is structural and fundamental. As a nonprofit health care system, Atlantic Health operates under a governance model in which the ultimate accountability for the institution’s mission, quality, financial stewardship, and community service rests with a board of unpaid community leaders who bring their professional expertise to the task because they believe in the institution’s purpose, not because compensation creates the incentive. The departing trustees collectively represent the kind of volunteer board leadership that this model works best when it can attract: individuals whose careers produced expertise directly relevant to the institution’s governance challenges, who maintained sustained engagement rather than nominal membership, and who translated their professional backgrounds into governance contributions with direct institutional consequence. The Gagnon Cardiovascular Institute, the accountable care networks, the audit and compliance oversight that protected the institution’s financial integrity across nearly two decades of market change, the governance structures that guided the system through four successful years under McCracken’s chair — these are among the tangible outcomes of the service now concluding. For Atlantic Health and for the New Jersey communities it serves, the measure of those contributions is ultimately found not in the governance committees these leaders chaired or the years they served, but in the institution’s continued capacity to deliver on a healthcare mission for millions of patients who will never know the names of the people in the room when the decisions that shaped their care were made.
